Heart Failure Drugs Market: Growth, Future Prospects & Competitive Analysis, 2018-2026

Market Insights

Heart failure occurs when the heart cannot pump blood at a rate sufficient to fulfill the needs of the metabolizing tissues. The heart’s pumping motion is primarily responsible for promptly delivering oxygen and nutrient-rich blood to all body cells. The human body can perform its normal functions when all the cells in the body get proper nourishment. However, the weaker heart can’t give enough blood to the cells in heart failure.

Heart failure affects almost 64.3 million individuals across the globe. The prevalence of recognized heart failure is between 1% and 2% of the overall adult population in affluent countries. Heart failure is considered a critical medical condition that generally doesn’t have a complete cure. However, when heart failure is treated with drugs and healthy lifestyle adjustments, many people with the illness can live a joyful life.

Report on the Key Takeaways

Recommended Medications for Heart Failure

Healthcare experts usually recommend a combination of medications for patients to ensure the proper treatment of heart failure. One or more medications can be prescribed based on the patient’s symptoms.

Beta-blockers:

These medications lower blood pressure and lower heart rate. It is pretty compelling and also allows you to live a healthy life by mainly reducing the symptoms and signs of heart failure and boosting overall heart function.

Positive inotropes:

People in the hospital with certain types of severe heart failure may get these drugs by IV. Positive inotropes can aid in the efficient pumping of blood and the maintenance of blood pressure.

Diuretics:

Diuretics, often known as “water tablets,” cause you to urinate more regularly and prevent fluid from building up in your body. Diuretics, such as furosemide, help reduce the fluid level in the lungs, making it easier for a human to breathe comfortably.

Vericiguat:

These newly developed medications are proving effective for treating heart failure. An oral soluble stimulator called guanylate cyclase is such a medicine, and it’s taken by mouth once a day. According to research, people with high-risk heart failure who took vericiguat had fewer heart failure hospital stays.

Recent Developments Related to Heart Failure

• According to a new study, an Apple Watch app could help diagnose left ventricular malfunction. A left-ventricular dysfunction is a type of disorder that occurs when the heart fails to pump blood effectively. The app performed comparably to a typical 12-lead EKG in the trial. According to experts, this could allow individuals to detect and monitor heart failure without contacting their doctor.
• As per the latest Phase 3 clinical trial findings, sacubitril-valsartan, a combination oral treatment, can effectively reduce pulmonary blood pressure. This licensed treatment can be helpful for people with pulmonary hypertension (PH) associated with heart failure.
• The findings of the EMPRISE real-world study, which studied Jardiance’s first five years of use in the United States, add to previous findings from the landmark EMPA-REG OUTCOME® trial. In adults with type 2 diabetes and established cardiovascular disease, Jardiance reduced hospitalization for heart failure by 35% when compared to a placebo.

Major Players Working on Heart Failure

AstraZeneca, Heartseed Inc., Abbott Laboratories, Bristol-Myers Squibb, Cardiora, Sardocor Corp., Bayer HealthCare, and Palatin Technologies are among the leading companies working on developing practical solutions for heart failure.

The Most Important Reasons to Buy This Report

• The pipeline insights feature heart failure medications with comprehensive coverage of the latest developments concerning strategic collaborations, advanced technology, and licensing.
• Detailed coverage of recent clinical studies, R&D activities, new drug approvals, investments, and other product-related developments
• Insights on companies working closely to develop newer solutions to overcome the limitations of existing medications